These authorities have mutually agreed to accept GMP inspection reports in lieu of another GMP inspection of their own, according to a statement published by the MHRA. The five authorities see mutual recognition as a highly effective tool to manage the increasing complexity in the manufacturing and supply chain of medicines in a timely manner. Other named benefits include a minimised burden on industry and the timely access to medicines.

Source:

MHRA: Consortium Statement